Deargen Companies
The company's platform advances the treatment of rare and intractable diseases through the integration of AI and collective intelligence and specializes in genome data analysis, biomarker prediction, molecule selection, and optimization, enabling clinicians to realize precision medicine by designing small molecules for new drugs.Deargen Company Profile: Valuation, Investors, Acquisition - Pitch…pitchbook.com/profiles/company/433921-42
.png)
Headquarters:
Daejeon, South Korea
Founded Date:
2016
Number Of Exists:
N/A
Employee Number:
11-50
Industry:
AI R&D Pharma (DPI)